rs138107415
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_005751.5(AKAP9):āc.41A>Cā(p.Lys14Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,614,076 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152196Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251048Hom.: 1 AF XY: 0.000155 AC XY: 21AN XY: 135718
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461762Hom.: 1 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 727198
GnomAD4 genome AF: 0.000597 AC: 91AN: 152314Hom.: 2 Cov.: 33 AF XY: 0.000618 AC XY: 46AN XY: 74464
ClinVar
Submissions by phenotype
Long QT syndrome 11 Uncertain:1
- -
Long QT syndrome Uncertain:1
This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 14 of the AKAP9 protein (p.Lys14Thr). This variant is present in population databases (rs138107415, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with AKAP9-related conditions. ClinVar contains an entry for this variant (Variation ID: 412028). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Benign:1
AKAP9: BS2 -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at